Feb 26, 2019 / 10:00PM GMT
Operator
Ladies and gentlemen, good afternoon. At this time, I would like to welcome everyone to the Theravance Biopharma conference call. (Operator Instructions) Today's conference call is being recorded. And now I'd like to turn the call over to Alex Dobbin, Head of Investor Relations. Please go ahead.
Alexander Dobbin - Theravance Biopharma, Inc. - Head of IR
Great. Thanks, Jonathon. Good afternoon, everyone. Thank you for joining our conference call and webcast to discuss our fourth quarter and full year 2018 financial results and business outlook. Joining us on the call today are Rick Winningham, Chief Executive Officer; Brett Haumann, Chief Medical Officer; and Jessica Stitt, Vice President of Finance.
Following some prepared remarks, we'll open the call for questions. A copy of the press release and the slides accompanying this call can be downloaded from our website, or you can call Investor Relations at 650-808-4045 and we'll be happy to assist you.
As always, I'll remind you that this conference call will contain forward-looking statements,
Q4 2018 Theravance Biopharma Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot